Cibus Opens Dedicated, High-throughput Gene Editing Facility for Trait Production

Stock Information for Cibus Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cibus Inc.

Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming
Cibus, Inc. Announces Closing of $27.5 Million Public Offering
USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA's Biotechnology Regulations
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering
Cibus, Inc. Announces Proposed Public Offering
Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat
Cibus to Participate in Alliance Global Partner's Annual Virtual Healthcare Company Showcase
Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.